VXRT Vaxart, Inc.

BEARISH Impact: 6/10 8-K
Horizon weeks Filed Apr 17, 2026 Processed 1mo ago SEC 0001437749-26-012623
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Latest settled — T+20d ⚠ clustered
VXRT ▼ -13.33% at T+20d
SHORT call ✓ call won +13.33% · α vs SPY +18.70% · entry $0.7500 → $0.6500
Next anchor: T+60d in 4w
Currently $0.5600 · +25.33% from $0.7500 entry (call sign-flipped)
Entry anchored
Apr 17, 2026
via day open
T+1d
+1.33%
call -1.33% · α -1.52%
$0.7600
settled 8w ago
T+5d
-4.00%
call +4.00% · α +4.55%
$0.7200
settled 7w ago
T+20d
-13.33%
call +13.33% · α +18.70%
$0.6500
settled 29d ago
T+60d
call — · α —
in 4w

Price Chart

Loading chart...

Executive Summary

Vaxart entered into a $25 million equity line agreement with Lincoln Park Capital, allowing it to sell shares over 24 months. The company issued 447,067 commitment shares to Lincoln Park and will file a registration statement for resale. Lincoln Park agreed not to engage in short selling.

Key Financial Metrics

Deal Value
$25.0M
Offering Size
$25.0M
Dilution
1.5%

Actionable Insight

Monitor for initial share sales under this agreement, which would signal immediate dilution. The 447,067 commitment shares represent immediate dilution of approximately 1.5% based on current share count. Watch for registration statement filing as the next catalyst.

Key Facts

  • Vaxart entered into a $25 million equity line agreement with Lincoln Park Capital
  • Company issued 447,067 commitment shares to Lincoln Park as consideration
  • Lincoln Park agreed not to engage in short selling or hedging transactions
  • Company has full discretion over timing and amount of share sales
  • Proceeds will be used for working capital, capital expenditures, and general corporate purposes

Financial Impact

Up to $25 million in potential dilution through equity financing

dilutioncashequity

Risk Factors

  • Significant shareholder dilution from potential $25 million in share sales
  • Downward pressure on stock price from regular share issuance
  • Company may be perceived as desperate for capital given OTC listing

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-012623
Exhibit: ex_947187.htm0001437749-26-012623
Exhibit: ex_947188.htm0001437749-26-012623
Document: vxrt20260417_8k.htm0001437749-26-012623
Document: 0001437749-26-012623-index-headers.html0001437749-26-012623
Document: 0001437749-26-012623-index.html0001437749-26-012623
Document: 0001437749-26-012623.txt0001437749-26-012623
12 reports for VXRT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VXRT — sortable, filterable
Type Now
Jun 8, 2026
4d ago
DEFA14A
NEUTRAL ★ 4/10
$0.6000 awaiting T+5awaiting T+5$0.5600 (−6.67%)
Jun 8, 2026
4d ago
DEFA14A
NEUTRAL ★ 4/10
$0.6200 awaiting T+5awaiting T+5$0.5600 (−9.68%)
Jun 1, 2026
11d ago
DEFA14A
NEUTRAL ★ 5/10
$0.6300 $0.6200▼ −1.59%▲ +1.16%$0.5600 (−11.11%)
May 20, 2026
24d ago
DEFA14A
NEUTRAL ★ 4/10
$0.6100 $0.6600▲ +8.20%▲ +6.39%$0.5600 (−8.20%)
May 20, 2026
24d ago
DEFA14A
NEUTRAL ★ 4/10
$0.6100 $0.6600▲ +8.20%▲ +6.39%$0.5600 (−8.20%)
May 19, 2026
24d ago
PREC14A
NEUTRAL ★ 4/10
$0.6100 $0.6600▲ +8.20%▲ +6.39%$0.5600 (−8.20%)
May 19, 2026
24d ago
DEFA14A
MIXED ★ 6/10
$0.6100 $0.6600▲ +8.20%▲ +6.39%$0.5600 (−8.20%)
May 1, 2026
6w ago
Press Release
BEARISH ★ 7/10
$0.7700 $0.7400▲ +3.90%▲ +6.24%$0.5600 (+27.27%)
Apr 21, 2026
7w ago
8-K
NEUTRAL ★ 3/10
$0.7600 $0.7800▲ +2.63%▲ +1.55%$0.5600 (−26.32%)
Apr 17, 2026
8w ago
8-K
BEARISH ★ 6/10
$0.7500 $0.7200▲ +4.00%▲ +4.55%$0.5600 (+25.33%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (49h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access